Stock listing
AY20 Stock Price, News, Filings & Events — Aytu Biopharma, Inc.
Selected listing: AY20 · GETTEX · EUR · DE
This page tracks Aytu Biopharma, Inc.'s AY20:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AY20:GETTEX. AY20:GETTEX is the stock-level entry point for investors researching Aytu Biopharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- AY20:GETTEX
- Asset type
- Stock
- Market cap
- $24.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- GETTEX
- Currency
- EUR
Aytu Biopharma, Inc. AY20:GETTEX stock context
This page tracks Aytu Biopharma, Inc.'s AY20:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AY20:GETTEX. AY20:GETTEX is the stock-level entry point for investors researching Aytu Biopharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Aytu Biopharma, Inc.
Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026
June 1, 2026
Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
May 18, 2026
Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results
May 13, 2026
Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026
May 6, 2026
Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
February 3, 2026
Aytu Biopharma, Inc. earnings calls
Aytu BioPharma, Inc. (AYTU) Q3 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call
February 3, 2026 · Replay with transcript and chapters
Aytu BioPharma, Inc. (AYTU) Q1 2026 Earnings Call
November 13, 2025 · Replay with transcript and chapters
Aytu BioPharma, Inc. (AYTU) Q4 2025 Earnings Call
September 23, 2025 · Replay with transcript and chapters
Aytu BioPharma, Inc. (AYTU) Q3 2025 Earnings Call
May 14, 2025 · Replay with transcript and chapters
Aytu BioPharma, Inc. (AYTU) Q2 2025 Earnings Call
February 12, 2025 · Replay with transcript and chapters
Research Aytu Biopharma, Inc.
Aytu Biopharma, Inc. investor report
Review AI stock analysis and investor report context for AY20:GETTEX.
Aytu Biopharma, Inc. company profile
View the public company page for Aytu Biopharma, Inc. on 6ix.
Aytu Biopharma, Inc. news
Read company news and market updates connected to Aytu Biopharma, Inc..
Aytu Biopharma, Inc. investor events
Find investor webinars, events, and replay context for Aytu Biopharma, Inc..
Alternate listings
AYTU:NASDAQ
US · USD
Alternate listing for Aytu Biopharma, Inc.; the primary context on this page is AY20:GETTEX.
AYTU:BOATS
US · USD
Alternate listing for Aytu Biopharma, Inc.; the primary context on this page is AY20:GETTEX.
AY20:MUN
DE · EUR
Alternate listing for Aytu Biopharma, Inc.; the primary context on this page is AY20:GETTEX.
A3D38R:LS
DE · EUR
Alternate listing for Aytu Biopharma, Inc.; the primary context on this page is AY20:GETTEX.
0A8M:LSE
GB · USD
Alternate listing for Aytu Biopharma, Inc.; the primary context on this page is AY20:GETTEX.
A3D38R:LSX
DE · EUR
Alternate listing for Aytu Biopharma, Inc.; the primary context on this page is AY20:GETTEX.